Eli Lilly launched an ad campaign on Friday, cautioning patients against the risks of unapproved weight-loss drugs in its ...

After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop ...

Once again, Eli Lilly is using Hollywood’s biggest night as a platform to speak out on a hot-button issue in pharma. | Once ...

Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.

People are always looking for a perfect diet plan. This popularity has led to scams involving weight loss formulas claiming to offer rapid results.

It’s hard to watch television without seeing advertisements for compounded GLP-1 weight-loss drugs cheaper than the authentic ...

The Super Bowl aired a Hims & Hers commercial that is receiving backlash for its non-FDA approved weight loss drug. This drug ...

Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...

But now there is good news for people taking weight loss medication who may be at risk ... risk of both depression and Alzheimer's disease (AD). Evidence suggests that depressive symptoms are ...

The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions ...

Earlier this month, Hims ran a Super Bowl ad touting the affordability of its weight loss drugs compared to those sold by big pharmaceutical companies. The ad sparked controversy for promoting ...